Drinking coffee may be associated with a lower risk of developing multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
Steven Schonholz, MD, FACS, will present a scientific poster on how BioZorb is used in the treatment of breast cancer at the 32nd Annual Miami Breast Cancer Conference, in Miami Beach, Fla., Feb. 26 to March 1.
Football helmet add-ons such as outer soft-shell layers, spray treatments, helmet pads and fiber sheets may not significantly help lower the risk of concussions in athletes, according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
The Endocrine Society today announced it has selected 22 winners of the Helmsley Charitable Trust Abstract Awards in Type 1 Diabetes.
Scientists have discovered a skin test that may shed new light on Alzheimer’s and Parkinson’s diseases, according to a study released today will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, D.C., April 18 to 25, 2015.
Breakthroughs and the latest research advances in endocrine-disrupting chemicals, nutrition, obesity, thyroid conditions and aging will be showcased in a series of press conferences at ENDO 2015, the Endocrine Society’s 97th Annual Meeting & Expo.
An analysis of data on roughly 87,500 men treated for prostate cancer since 2005 finds a notable increase in higher-risk cases of the disease between 2011 and 2013. The study will be presented at the upcoming 2015 Genitourinary Cancers Symposium in Orlando.
An analysis of data on 945 patients with prostate cancer that is managed with active surveillance shows differences in outcomes depending on whether the patient was low or intermediate risk at diagnosis. Compared to patients with low-risk disease, those with intermediate-risk cancer (PSA >10ng/ml or Gleason score 7 or clinical stage T2b/2c) had a nearly four-fold higher chance of dying from prostate cancer within 15 years. The study will be presented at the upcoming 2015 Genitourinary Cancers Symposium in Orlando.
A case-control study of close to 180,000 men suggests that the incidence of prostate cancer is higher among men with a history of testicular cancer (12.6 percent) than among those without a history of testicular cancer (2.8 percent). Men who have had testicular cancer were also more likely to develop intermediate- or high-risk prostate cancers. The study will be presented at the upcoming 2015 Genitourinary Cancers Symposium in Orlando.
ALEXANDRIA, Va. – Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis. The study will be presented at the upcoming 2015 Genitourinary Cancers Symposium in Orlando.
Helping to advance scientific and clinical knowledge to combat cancers that affect the bladder, kidneys, urinary tract and male reproductive organs, physician scientists at Rutgers Cancer Institute of New Jersey are presenting their latest research in this area at the 2015 Genitourinary Cancers Symposium. At focus are studies examining radical cystectomies and patients with uncontrolled diabetes and a look at how laparoscopic and robotic surgeries have evolved in adrenal cancers.
Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania’s Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.
A doctor’s recommendation and a patient’s race may influence flu vaccination rates, according to researchers at Henry Ford Hospital in Detroit. Researchers found that 90 percent of patients received vaccination if their physician advocated for it compared to 58 percent of patients whose physician did not.
People who exhibit a resistance to aspirin may be more likely to have more severe strokes than people who still respond to the drug, according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
Preteens who experiment or explore new things may have brain processes that work differently than those of preteens who do not, according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
Henry Ford Hospital researchers say that breastfeeding and other factors influence a baby’s immune system development and susceptibility to allergies and asthma by what’s in their gut.
Women with multiple sclerosis (MS) may have lower levels of important antioxidant and anti-inflammatory nutrients, such as folate from food and vitamin E, than healthy people, according to a new study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
Chemicals used as synthetic flame retardants that are found in common household items such as couches, carpet padding, and electronics have been found to cause metabolic and liver problems that can lead to insulin resistance, which is a major cause of obesity, according to new research from the University of New Hampshire.
A new treatment may bring hope for people who suffer from muscle cramps or spasms from neuromuscular disorders, diseases such as multiple sclerosis or simply from nighttime leg cramps that keep people from sleeping, according to a study released today that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC, April 18 to 25, 2015.
From many clinical researchers presenting findings at Cardiology 2015, conference organizers chose 8 finalists for the Outstanding Investigator Award. Their research in pediatric cardiology is summarized below.
Using mannequins and other and simulated education techniques can significantly improve the knowledge, skills and confidence of first-year neurology residents treating stroke patients in the ER, according to a study presented at the International Stroke Conference 2015.
An international group of more than 800 medical experts at the nation’s largest pediatric cardiology conference are discussing challenges in treating congenital heart disease in fetuses, neonates, children and young adults.
A large percentage of the world's population -- fully one third, by the World Health Organization's estimates -- is currently overweight or obese. This staggering statistics has made finding ways to address obesity a top priority for many scientists around the globe, and now a group of researchers at the University of Wyoming has found promise in the potential of capsaicin -- the chief ingredient in chili peppers -- as a diet-based supplement.
Good drugs are hard to design: they must not only effectively treat a medical condition, but they must also do so without having side effects that outweigh their benefits. Sometimes, toxic side effects aren’t discovered until late in development, when substantial time and money have already been invested. Now, researchers have devised a new drug screen that capitalizes on the tendency of toxic compounds to alter the properties of the lipid bilayer that encases cells.
By employing derivatives of humanin, a naturally occurring peptide encoded in the genome of cellular mitochondria, researchers at Ben Gurion University of the Negev are working to interrupt necrosis, buying precious time for tissues whose cellular mechanisms have called it quits.
A research collaboration between Intermountain Healthcare, the University of Utah’s Obstetrics and Gynecology Department, and the University of Utah’s Psychiatry Department found that induced or augmented labor does not result in an increased risk of children developing autism spectrum disorder (ASD).
Three-dimensional (3D) printing can effectively create a biodegradable tracheal segment containing a patient’s own cells for use in complex tracheal reconstruction.
A novel, minimally invasive approach appears safe for treating life-threatening aneurysms that occur in the deepest part of the aorta, making it easier for surgeons to repair the aorta without opening the chest and easier for patients to recover
A new surgical training model that simulates patient bleeding is providing cardiothoracic surgery residents with “real-life” experience without compromising patient safety
Patients who receive red blood cell transfusions during coronary artery bypass grafting (CABG) surgery are at an increased risk of developing pneumonia
Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, itchy and tender scars. The study is the first to demonstrate that an altered AHNAK gene may have a significant biological role in keloid development.
The International Neuromodulation Society 12th World Congress in Montreal June 6 - 11, 2015 features traditional and cutting-edge ways to address chronic disease through interfacing with the body’s nervous system.
The Endocrine Society today announced it has selected 14 accomplished endocrinologists as winners of the organization’s prestigious 2015 Laureate Awards.
According to a new study led by researchers at Dana-Farber Cancer Institute, clinical trial patients with metastatic colorectal cancer who had high levels of vitamin D in their bloodstream prior to treatment with chemotherapy and targeted drugs, survived longer, on average, than patients with lower levels of the vitamin. Those findings were reported today at the 2015 American Society of Cancer Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco.
Members of the media can now register to attend the Endocrine Society’s Annual Meeting & Expo. The event featuring the latest advances in hormone health and science will be held in San Diego March 5-8, 2015.
"We're on the cusp of a major revolution in the way we treat breast cancer," says University of Colorado Cancer Center investigator, Jennifer Richer, PhD.
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial.
Loyola researchers and collaborators have reported promising results from a novel therapeutic approach for women with estrogen-receptor-positive breast cancer.
University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while traveling through the body in order to seed new tumor sites.
A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer.
In patients with metastatic triple-negative breast cancer, infusion of pembrolizumab produced durable responses in almost one out of five patients. One of the 27 patients had a complete response and four had a partial response. Seven more patients had stable disease.
James Ingle, M.D., an internationally recognized breast cancer expert, will receive the 2014 William L. McGuire Memorial Lecture Award on Dec. 10 at the 2014 San Antonio Breast Cancer Symposium.
As governments, industry and public interest groups from across the globe prepare to meet next week to discuss endocrine-disrupting chemicals and other international chemical safety issues, the Endocrine Society and IPEN released a new guide documenting the threat endocrine-disrupting chemicals (EDCs) pose to human health.
Research from Rutgers Cancer Institute of New Jersey shows that a combination of doxil, carboplatin and bevacizumab is a well-tolerated treatment regimen in patients with metastatic triple-negative breast cancer who received no prior treatment for their metastatic disease. The work, which also included genomic profiling to measure molecular correlates of response, is being presented at the San Antonio Breast Cancer Symposium being held this week in Texas.
If approved, Iomab-B should increase the number of patients eligible for curative bone marrow transplant (BMT, also known as HSCT) and improve clinical outcomes.
Since intensive chemotherapy is associated with a high mortality rate and limited benefits to high risk patients, low intensity treatments such as Actimab-A could potentially extend overall survival in elderly patients while significantly decreasing traditional chemotherapy related toxicities, including treatment related early mortality.
A study that investigated the potential of the compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis (scarring) in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.
In a poster presentation, Jane Little, MD, of Seidman Cancer Center at University Hospitals Case Medical Center, and colleagues presented promising findings related to a novel biochip aimed at improving outcomes for patients with sickle cell disease. Although it is well-known that red cell interactions are important in sickle cell disease, the technology to date has not allowed physician-scientists to evaluate these properties on a large scale basis. This innovative biochip, which evaluates the biophysical properties of red blood cells in sickle cell patients, has the potential to become a standard test for monitoring the disease because of its widespread applicability and its use of only small volumes of blood.
Three studies presented at the American Epilepsy Society's (AES) 68th Annual Meeting offer new insights into diverse patient experiences with CBD.
Three studies exploring the efficacy and safety in the development of a purified and formulated form of cannabis called Epidiolex will be presented at the American Epilepsy Society's (AES) 68th Annual Meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right